Skip to main content
main-content

Obesity, diet, & lifestyle interventions


Browse the latest news, expert commentary, and educational content on obesity and lifestyle interventions.


Highlights

10-19-2021 | Tirzepatide | News

Tirzepatide preferable to glargine when OADs fail in SURPASS-4

Tirzepatide provides better glucose control than insulin glargine in people with type 2 diabetes taking multiple oral antidiabetes medications, report the SURPASS-4 investigators in The Lancet.

10-13-2021 | Hypoglycemia | View from the clinic | Article

Endemic hypoglycemia

In the final article in this series, Sanjay Kalra highlights region-specific causes of hypoglycemia requiring a tailored management approach.

07-15-2021 | Epidemiology | News

Global variation in optimal BMI, age cutoffs for diabetes screening

Researchers find large geographic differences in the influence of BMI and age on the risk for type 2 diabetes in low- and middle-income countries.

Semaglutide for weight loss: The STEP and SELECT trials

Get the latest results and insights from the researchers.

More on obesity & lifestyle interventions

10-26-2021 | Type 2 diabetes | Conference report | Article

Conference report: SAFES summit 2021

October 2, 2021: Kathmandu, Nepal

10-13-2021 | Hypoglycemia | View from the clinic | Article

Endemic hypoglycemia

DiRECT: Type 2 diabetes remission through weight management

Primary findings, 2-year outcomes and translating this landmark trial into practice

Stay informed with Medicine Matters

Get the latest developments in diabetes delivered straight to your inbox

Image Credits